Pluri Secures $6.5M Investment, Acquires Cacao Company
Pluri Inc. secured a $6.5 million private investment from Alejandro Weinstein, who will join the company’s board. Simultaneously, Pluri...
Tiziana Life Sciences’ Nasal Spray Shows Promise in Spinal Cord Injury Treatment
Tiziana Life Sciences announced positive preclinical results for their intranasal anti-CD3 monoclonal antibody, foralumab, in treating traumatic spinal cord...
MiNK Therapeutics Allo-INKTs + BOT/BAL for Advanced Gastroesophageal Cancers
MiNK Therapeutics announced a presentation at the ASCO GI Symposium detailing a Phase 2 trial of its iNKT cell...
Outlook Therapeutics ON5-5010 Wet AMD Trial Results: Efficacy & Safety Unveiled
Outlook Therapeutics presented 12-week data from its NORSE EIGHT clinical trial of ONS-5010 (bevacizumab-vikg) for wet age-related macular degeneration...
Ampligen Clinical Trial Results Published for Post-COVID Conditions
AIM ImmunoTech Inc. announced final clinical study results (AMP-518) for Ampligen in treating post-COVID conditions, specifically fatigue. The study,...
Quoin Pharma QRX003 Shows Promising Netherton Syndrome Results
Quoin Pharmaceuticals announced further clinical evidence supporting the efficacy of QRX003, its topical treatment for Netherton Syndrome. Data from...
Exicure and GPCR Therapeutics Announce Acquisition
Exicure, Inc. acquired GPCR Therapeutics USA Inc. and entered into a licensing and collaboration agreement with GPCR Therapeutics Inc....
LB-102 LB Pharma Segal Trial Shows Promising Phase 2 Schizophrenia Results
Segal Trials, a clinical research network specializing in psychiatric disorders, significantly contributed to the successful Phase 2 trial of...
ExThera’s Sepsis Trial Wins Mtec Award
ExThera Medical received funding from the Medical Technology Enterprise Consortium (MTEC) for a randomized controlled trial. The trial will...
Needle-Free Thermostable mRNA Vaccines Advance with $4.8M Funding
Vaxxas, a clinical-stage biotech company, is developing a heat-stable, dried-formulation mRNA vaccine delivered via its microarray patch (HD-MAP) with...